Linear Capital portfolio company **Baiyi Huixin** launches **DetecMicro**, a vascular interventional surgery planning software

On June 16, 2023, the "Seeing the Small to Know the Great, Motion to See the Future" Baiyi Huixin product launch event was held in Beijing, where the DetecMicro vascular interventional surgical planning software was officially unveiled!

Built on simulation technology, this software enables refined analysis of patient vascular structures, providing comprehensive guidance and support for clinicians performing vascular interventional procedures — a better medical tool for doctors and researchers committed to improving patient outcomes and pursuing higher standards of care.

At the launch event, the DetecMicro vascular interventional surgical planning software drew significant attention from industry experts for its precise positioning technology and outstanding application performance.

As medical standards continue to advance, vascular interventional surgery has gradually become the mainstream treatment for vascular diseases, bringing new hope to patients. However, vascular surgery in China faces a lack of domestic foundational tools, low accuracy in existing tools, and foreign tools ill-suited to local clinical scenarios — improving surgical quality and efficiency has become an industry-wide priority.

In recent years, the government has issued multiple policy documents, including the "14th Five-Year Plan for National Clinical Specialty Capacity Building" and the "14th Five-Year Plan for Medical Equipment Industry Development," aimed at strengthening frontier technological capabilities in medical devices and encouraging deeper collaboration between medical equipment companies, research institutes, and healthcare institutions to benchmark against international standards and advance clinical application innovation.

Qian Peidong, General Manager of Baiyi Huixin: "Our innovation philosophy is to go from the clinic to the clinic. We use cutting-edge technology to solve real clinical problems. When designing products, we don't just think from an engineer's perspective — we put ourselves in the user's shoes and focus on what clinicians actually need."

The core philosophy of the Baiyi Huixin team is the integration of medicine and engineering — truly going from the clinic to the clinic. By deeply understanding clinical needs and combining frontier technology with real-world demands, they build products that clinicians genuinely need.

At the launch, representatives from the DetecMicro R&D team introduced the software's design concept, module functions, and clinical application results.

Meanwhile, in presentations by Professor Chen Bing and Professor Yang Chao that combined real clinical cases, they demonstrated the software's highly clinical-relevant features and application scenarios, as well as the outstanding performance it has validated in clinical practice.

Today, medical technology is evolving toward digitalization, intelligence, personalization, and precision. Medical-engineering innovations like the DetecMicro vascular interventional surgical planning software are actively exploring and expanding a new platform, a new caliber of capability for China's vascular surgery field.

In his closing remarks, Professor Chen Zhong noted that the birth of DetecMicro 1.0 provides physicians with more precise data to complete successful, optimal surgeries, while the leap to DetecMicro 2.0 enables the transformation from morphology to functional assessment. He looks forward to the day when advanced medical software tools can output standardized parameters for vascular surgery, establishing China's own evaluation systems and standardized tools. The launch of the DetecMicro vascular interventional surgical planning software marks a milestone event in China's medical technology sector. It signifies not only a breakthrough and advancement in domestic medical technology, but more importantly, it brings new hope and prospects to the field of vascular surgery.

Professor Fu Weiguo

Professor Guo Wei

Professor Wang Yuqi

Professor Wang Shenming

Professor Fu Weiguo: The precise data provided by DetecMicro will offer an entirely new platform for medical research and give surgeons a solid foundation for their procedures, making them more confident in the operating room.

Professor Guo Wei: We are always pursuing higher standards. I hope the Baiyi Huixin team can solve 100% of the pain points that exist in clinical practice.

Professor Wang Yuqi: Digitalization has permeated every aspect of our lives. I believe you will lead the global trend!

Professor Wang Shenming: I look forward to Baiyi Huixin's future products developing along the trajectory of datafication and informatization!

[ Scroll up and down for more details ]

Medical innovation comes from practice and is applied to practice. From DetecMicro's product breakthrough to more precise data measurement, more intuitive and comprehensive hemodynamic evaluation tools, and more efficient, integrated case management, Baiyi Huixin remains focused on clinical needs and continues to integrate technological innovation!

Baiyi Huixin General Manager Qian Peidong stated that going forward, Baiyi Huixin will work hand-in-hand with expert teams to develop hardcore products that truly meet clinical needs, tailored to China's national conditions! Let us look forward to Baiyi Huixin's next steps and the boundless possibilities ahead for China's medical industry!

Gathering for Innovation, Discussing the New Future of Chinese Manufacturing

The debut of the DetecMicro vascular interventional surgical planning software will inject new vitality into the development of China's medical technology and healthcare sectors. "Seeing the Small to Know the Great, Motion to See the Future" — we look forward to deeper and broader applications of emerging technologies in healthcare, making greater contributions to human health.

Click here to read the original article